Related Experiment Video
Updated: Jun 22, 2026
03:36
Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
Neopterin, a prognostic marker in human malignancies.
Robert Sucher1, Katharina Schroecksnadel, Guenter Weiss
1Center of Operative Medicine, Department of Visceral, Transplant, and Thoracic Surgery, Innsbruck Medical University, Austria.
Cancer Letters
|June 9, 2009
Summary
Elevated neopterin levels indicate an active immune response, often seen in cancer. Measuring neopterin aids in understanding cancer progression and immune system interactions.
Area of Science:
- Immunology
- Oncology
- Biochemistry
Background:
- Increased neopterin concentrations are linked to activated cellular immune responses, including allograft rejection, viral infections, autoimmune disorders, and cancers.
- Neopterin levels in cancer patients often correlate with disease progression and predict shorter survival.
- Neopterin is released by macrophages and dendritic cells upon stimulation with interferon-gamma, reflecting immune activation.
Purpose of the Study:
- To explore the role of neopterin as a biomarker in various immune-mediated conditions and cancer.
- To investigate the relationship between neopterin concentrations and disease course in cancer patients.
- To understand the immunological network and its interaction with tumor pathogenesis through neopterin measurement.
Main Methods:
- Measurement of neopterin concentrations in body fluids (urine, serum/plasma, ascites).
- Correlation analysis of neopterin levels with disease status and patient survival.
- Investigation of neopterin release from immune cells stimulated by pro-inflammatory cytokines like interferon-gamma.
Main Results:
- Neopterin concentrations are elevated in conditions with activated cellular immunity.
- In cancer patients, neopterin levels parallel disease progression and serve as an independent predictor of survival.
- Neopterin release from monocytes/macrophages and dendritic cells is triggered by interferon-gamma.
Conclusions:
- Neopterin measurement is a valuable diagnostic tool reflecting immune activation status.
- Understanding neopterin's role enhances comprehension of tumor-induced immune escape and tolerance.
- Neopterin serves as a biomarker for immune activation in various diseases, particularly cancer.
Related Concept Videos
02:55The Nucleolus
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...